Tayo Fabusuyi is an assistant research scientist in the Human Factors Group at UMTRI. His research interests are in Urban Systems and Operations Research, specifically designing and implementing initiatives that support sustainable and resilient communities with a focus on efficiency and equity issues. Drawing on both quantitative and qualitative data, his research develops and applies hard and soft Operations Research methods to urban systems issues in a manner that emphasizes theory driven solutions with demonstrated value-added. A central theme of his research activities is the use of demand side interventions, via information and pricing strategies in influencing the public’s travel behavior with the objective of achieving more beneficial societal outcomes. Informed by the proliferation of big data and the influence of transportation in the urban sphere, these research activities are categorized broadly into three overlapping and interdependent areas – intelligent transportation systems (ITS), emerging mobility services and urban futures. Before joining the research faculty at UMTRI, Dr. Fabusuyi was a Planning Economist at the African Development Bank and an adjunct Economics faculty member at Carnegie Mellon University, where he received his Ph.D. in Engineering and Public Policy.
My research interest lies in applying data science for actionable transformation of human health from the bench to bedside. Current research focus areas include cutting edge single-cell sequencing informatics and genomics; precision medicine through integration of multi-omics data types; novel modeling and computational methods for biomarker research; public health genomics. I apply my biomedical informatics and analytical expertise to study diseases such as cancers, as well the impact of pregnancy/early life complications on later life diseases.
The current goal of our research is to learn enough about the physiology and ecology of microbes and microbial communities in the gut that we are able to engineer the gut microbiome to improve human health. The first target of our engineering is the production of butyrate – a common fermentation product of some gut microbes that is essential for human health. Butyrate is the preferred energy source for mitochondria in the epithelial cells lining the gut and it also regulates their gene expression.
One of the most effective ways to influence the composition and metabolism of the gut microbiota is through diet. In an interventional study, we have tracked responses in the composition and fermentative metabolism of the gut microtiota in >800 healthy individuals. Emerging patterns suggest several configurations of the microbiome that can result in increased production of butyrate acid. We have isolated the microbes that form an anaerobic food web to convert dietary fiber to butyrate and continue to make discoveries about their physiology and interactions. Based on these results, we have initiated a clinical trial in which we are hoping to prevent the development of Graft versus Host Disease following bone marrow transplants by managing butyrate production by the gut microbiota.
We are also beginning to track hundreds of other metabolites from the gut microbiome that may influence human health. We use metagenomes and metabolomes to identify patterns that link the microbiota with their metabolites and then test those models in human organoids and gnotobiotic mice colonized with synthetic communities of microbes. This blend of wet-lab research in basic microbiology, data science and in ecology is moving us closer to engineering the gut microbiome to improve human health.
In the area of multi-scale modeling of manufacturing processes: (a) Models for understanding the mechanisms of forming and joining of lightweight materials. This new understanding enables the development of advanced processes which remove limitations of current state-of-the-art capabilities that exhibit limited formability of high strength lightweight alloys, and limited reproducibility of joining quality; (b) Innovative multi-scale finite element models for ultrasonic welding of battery tabs (resulting in models adopted by GM for designing and manufacturing batteries for the Chevy Volt), and multi-scale models for ultrasonic welding of short carbon fiber composites (resulting in models adopted by GM for designing and manufacturing assemblies made of carbon fiber composites with metallic parts); (c) Data-driven algorithms of prediction geometrical and microstructural integrity of the incremental formed parts. Machine learning is used for developing fast and robust methods to be integrated into the designing process and replace finite element simulations.
My lab has two main areas of focus: molecular characteristics of head and neck cancer, and the intersection of regulatory genomics and pathway analysis. With head and neck cancer, we study tumor subtypes and biomarkers of prognosis, treatment response, and recurrence. We perform integrative omics analyses, dimension reduction methods, and prediction techniques, with the ultimate goal of identifying patient subsets who would benefit from either an additional targeted treatment or de-escalated treatment to increase quality of life. For regulatory genomics and pathway analysis, we develop statistical tests taking into account important covariates and other variables for weighting observations.
The Aguilar group is focused understanding transcriptional and epigenetic mechanisms of skeletal muscle stem cells in diverse contexts such as regeneration after injury and aging. We focus on this area because there are little to no therapies for skeletal muscle after injury or aging. We use various types of in-vivo and in-vitro models in combination with genomic assays and high-throughput sequencing to study these molecular mechanisms.
My methodological research focus on developing statistical methods for routinely collected healthcare databases such as electronic health records (EHR) and claims data. I aim to tackle the unique challenges that arise from the secondary use of real-world data for research purposes. Specifically, I develop novel causal inference methods and semiparametric efficiency theory that harness the full potential of EHR data to address comparative effectiveness and safety questions. I develop scalable and automated pipelines for curation and harmonization of EHR data across healthcare systems and coding systems.
Our laboratory focuses on (1) the biology of cancer metastasis, especially bone metastasis, including the role of the host microenvironment; and (2) mechanisms of chemoresistance. We explore for genes that regulate metastasis and the interaction between the host microenvironment and cancer cells. We are performing single cell multiomics and spatial analysis to enable us to identify rare cell populations and promote precision medicine. Our research methodology uses a combination of molecular, cellular, and animal studies. The majority of our work is highly translational to provide clinical relevance to our work. In terms of data science, we collaborate on applications of both established and novel methodologies to analyze high dimensional; deconvolution of high dimensional data into a cellular and tissue context; spatial mapping of multiomic data; and heterogenous data integration.
Our research aims to address fundamental problems in both biomedical research and computer science by developing new tools tailored to rapidly emerging single-cell omic technologies. Broadly, we seek to understand what genes define the complement of cell types and cell states within healthy tissue, how cells differentiate to their final fates, and how dysregulation of genes within specific cell types contributes to human disease. As computational method developers, we seek to both employ and advance the methods of machine learning, particularly for unsupervised analysis of high-dimensional data. We have particular expertise in manifold learning, matrix factorization, and deep learning approaches.
My research interests are in natural language semantics and psycholinguistics, focusing on verbs. I conduct behavioral psycholinguistic experiments with methodologies such as self-paced reading and maze tasks, as well as surveys of linguistic and semantic judgments. I also study semantic variation using corpora and datasets such as the Twitter Decahose, to better understand how words have developed diverging meanings in different communities, age groups, or regions. I use primarily R and Python to collect, manage, and analyze data. I direct the UM WordLab in the linguistics department, working with students (especially undergraduates) on experimental and computational research focusing on lexical representations.